.Merck beats incomes desires, brings up sales overview on solid demand for leading medicines like Keytruda CNBCMerck & Co. (MRK US) Defeats Earnings Projections as Keytruda Purchases Rise BloombergMerck Sell: Pharma Titan Posts Strong Outcomes, However Expectation Tumbles Short Real estate investor's Service DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats profit as well as sales expectations among Keytruda advantage, yet delivers mixed full-year overview MarketWatch.